This information was published on 2026-06-11T02:29:23 for IP Right Filed Published.
| Field | Value |
| (210) | 2661642 (IR 1921711) |
| (220) |
16 Apr 2026
|
| (300) |
US, 04 Nov 2025, 99479136
|
| (500) |
The mark consists of the stylized wording, "ZENDDMYA" where the letters, "ZEN" and "MYA" are featured in dark blue, while the letters, "DD" are featured in a gradient color pattern from dark blue at the bottom of the letters to light blue at the top.
The colors dark blue and light blue are claimed as a feature of the mark. The mark consists of the stylized wording, "ZENDDMYA" where the letters, "ZEN" and "MYA" are featured in dark blue, while the letters, "DD" are featured in a gradient color pattern from dark blue at the bottom of the letters to light blue at the top. |
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of cancer and tumors, and autoimmune diseases and disorders; biological preparations for the treatment of cancer; biologics in the nature of pharmaceutical preparations for the treatment of cancer. |
| (540) |
|
| (550) | Figurative |
| (730) |
Kite Pharma, Inc.
|
Find out more about publications on the About page.